Rosaria Oteri

Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP

Isabella Venza, Maria Visalli, Rosaria Oteri et al. · International Immunopharmacology · 2014 · 45 citations

Oncology, Medicine, Melanoma +7

Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma

Mario Venza, Maria Visalli, Teresa Catalano et al. · Biochemical and Biophysical Research Communications · 2013 · 45 citations

Medicine, Epigenetic Change, Melanoma +11

Class <scp>II</scp>‐specific histone deacetylase inhibitors <scp>MC</scp>1568 and <scp>MC</scp>1575 suppress <scp>IL</scp>‐8 expression in human melanoma cells

Isabella Venza, Maria Visalli, Rosaria Oteri et al. · Pigment Cell & Melanoma Research · 2012 · 43 citations

Immunology, Dermatology, Cancer Biology +17

Epigenetic marks responsible for cadmium-induced melanoma cell overgrowth

Mario Venza, Maria Visalli, Carmelo Biondo et al. · Toxicology in Vitro · 2014 · 39 citations

Chromatin, Epigenetic Change, Epigenomics +4

Genistein reduces proliferation of EP3-expressing melanoma cells through inhibition of PGE2-induced IL-8 expression

Isabella Venza, Maria Visalli, Rosaria Oteri et al. · International Immunopharmacology · 2018 · 36 citations

Chemoprevention Strategy, Ep3-expressing Melanoma Cells, Melanoma +6